Coronavirus vaccines may eventually be administered in the form of a pill, Nadhim Zahavi suggests.
The vaccine minister said that injections may not be the only option for receiving doses in the future but to ensure that the healthy capacity of supply remains a priority for the government.
Speaking to Times Radio, Mr. Zahavi said: “Pills and others are being developed around the world and we will continue to see those.
“But we are ensuring that the UK will always have the ability and capability to manufacture vaccines that will deal with any type of virus.”
When asked about a slump for the first jobs when the second jobs are rolled out, Mr. Zahavi said: “We’ve got the ability to do the first and second jobs. The limiting factor is the supply of vaccines.”
Getting a vaccine jab through a pill can help reduce supply issues that have hampered rollout in some areas of the world with Europe.
Last month, a British biotech breakthrough indicated the possibility of converting injection vaccines into tablets as clinical trials in monkeys showed them to be highly effective oral vaccines in immunizing with viruses.
Sussex-based IoBio and California’s ImmunityBio have been applying for regulatory approval to run the trial in the UK since the pill’s clinical trials began on Americans in January.
IosBio’s chief executive, Wayne Chenone, said: “With our capsules you won’t need medical professionals to administer the vaccine, you can send it to Amazon Prime and have everyone immunized by Saturday.”
Other experts have said that new methods of administering the vaccine are needed.
Kate Bingham, former chair of the UK Vaccine Taskforce, said the process needed to be spread, suggesting that people should be allowed self-administration pills, nasal sprays and patches.
Speaking for BBC Radio 4 last month today The program, Ms. Bingham, said: “We need to improve vaccine formats because, clearly, two injections given by health professionals are not a good way to deliver vaccines.
“We need to get vaccine formats that are much more scalable and deliverable, so, whether they are pills or patches or nasal sprays, we need to find better ways to develop and deliver vaccines, and we can fix that. We will do it the same way. We have been doing this for the last few months. “